Tag Archives: nasal

FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression

Print this page March 5, 2019 — The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting… Read More »

FDA approves ketamine-derived nasal spray to treat depression

search2 Video Live Shows Good Morning America World News Tonight Nightline 20/20 This Week The View What Would You Do? Sections U.S. Politics International Entertainment Lifestyle Health Virtual Reality Technology Weather Sports FiveThirtyEight Privacy Policy Your CA Privacy Rights Children’s Online Privacy Policy Interest-Based Ads Terms of Use Contact Us ©2019 ABC News Internet Ventures.… Read More »